New York: Pfizer, Moderna, Novavax: executives at several American laboratories developing COVID-19 vaccines have recently pocketed millions of dollars by selling shares in their companies - raising questions about the propriety of such a move in the midst of a national health crisis. On the very day that pharmaceutical giant Pfizer announced preliminary data showing its vaccine was 90 per cent effective against the coronavirus, its chief executive Albert Bourla sold shares worth $5.6 million. There was nothing illegal about this, Pfizer said: the sale took place according to rules allowing company heads to sell shares under predetermined criteria, at a date or for a price set in advance, t
Hence then, the article about covid 19 as lab executives sell shares worth millions questions arise was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( COVID-19: As lab executives sell shares worth millions, questions arise )